Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Con

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Crohn'S & Colitis|July 24, 2021
The Reliability and Accuracy of Endoscopic Items and Scores Used in the Assessment of the Ileoanal Pouch and CuffZaid S Ardalan, Danny Con, Sujievvan Chandran, et al.
Digestive Diseases and Sciences|March 2, 2026
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency DepartmentChristopher F D Li Wai Suen, Shipraa Kaul, Ethan X Z Tan, et al.
Journal of Crohn'S & Colitis|July 24, 2021
Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation and its Location in Patients with an Ileoanal PouchZaid S Ardalan, Antony B Friedman, Danny Con, et al.
World Journal of Transplantation|September 19, 2024
Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective studyWilliam Chung, Kevin Wong, Noel Ravindranayagam, et al.
Journal of Crohn'S & Colitis|September 19, 2020
Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn's DiseaseDanny Con, Nina Parthasarathy, Maria Bishara, et al.
Inflammatory Bowel Diseases|April 24, 2026
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitisManjeet K Goyal, Priyata Dutta, Matthew C Choy, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2020
Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel diseaseAbhinav Vasudevan, Nina Parthasarathy, Danny Con, et al.
Journal of Gastroenterology and Hepatology|October 10, 2025
IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, AustraliaUma Mahadevan, Vipul Jairath, Jakob Begun, et al.
Gastroenterology|March 27, 2025
Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease ActivityRalley E Prentice, Emma K Flanagan, Emily K Wright, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Crohn'S & Colitis|July 24, 2021
The Reliability and Accuracy of Endoscopic Items and Scores Used in the Assessment of the Ileoanal Pouch and CuffZaid S Ardalan, Danny Con, Sujievvan Chandran, et al.
Digestive Diseases and Sciences|March 2, 2026
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency DepartmentChristopher F D Li Wai Suen, Shipraa Kaul, Ethan X Z Tan, et al.
Journal of Crohn'S & Colitis|July 24, 2021
Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation and its Location in Patients with an Ileoanal PouchZaid S Ardalan, Antony B Friedman, Danny Con, et al.
World Journal of Transplantation|September 19, 2024
Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective studyWilliam Chung, Kevin Wong, Noel Ravindranayagam, et al.
Journal of Crohn'S & Colitis|September 19, 2020
Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn's DiseaseDanny Con, Nina Parthasarathy, Maria Bishara, et al.
Inflammatory Bowel Diseases|April 24, 2026
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitisManjeet K Goyal, Priyata Dutta, Matthew C Choy, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2020
Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel diseaseAbhinav Vasudevan, Nina Parthasarathy, Danny Con, et al.
Journal of Gastroenterology and Hepatology|October 10, 2025
IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, AustraliaUma Mahadevan, Vipul Jairath, Jakob Begun, et al.
Gastroenterology|March 27, 2025
Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease ActivityRalley E Prentice, Emma K Flanagan, Emily K Wright, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Pageof 7